Toll-like receptor 3 (TLR 3) polymorphisms predisposition to schizophrenia and bipolar disorder

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Abnormal Toll-like receptor 3 (TLR 3) inflammatory response is implicated in schizophrenia (SCZ) and bipolar disorder (BD) pathophysiology.
• The genetic basis of TLR 3's contribution to SCZ and BD onset remains unclear.
• This study investigates the predisposition of TLR 3 functional variants L412F and F459L in SCZ and BD.

Purpose of the Study:

• To examine the genetic predisposition of TLR 3 functional variants L412F (rs3775291) and F459L (rs3775290) in schizophrenia and bipolar disorder.
• To determine if TLR 3 variants are associated with specific clinical features or treatment outcomes in these disorders.

Main Methods:

• A case-control study involving 260 controls, 260 SCZ patients, and 130 BD patients.
• Genotyping using PCR-RFLP to analyze frequencies of genotypes, alleles, and haplotypes.
• Statistical analyses adjusted for gender and age, with Bonferroni correction for validation.

Main Results:

• The L412F variant showed a significantly higher frequency in controls compared to BD patients (p_adjusted=0.004), suggesting a protective role.
• BD patients with L412F AA+GA genotypes had lower BPRS scores pre-treatment (p=0.001).
• The F459L variant was elevated in SCZ paranoid subgroup (p=0.004) and predicted decreased SANS scores post-treatment (p<10^-4).

Conclusions:

• The L412F variant may act as a protective genetic factor against the onset of bipolar disorder.
• The F459L variant might be a genetic risk factor for the paranoid subtype of schizophrenia.
• F459L could serve as a potential genetic predictor for improved treatment response in SCZ negative symptoms.